• OPEN AN ACCOUNT
Indian Indices
Sensex
73,580.54 -1,247.71
( -1.67%)
Global Indices
Nasdaq
51,527.73 -356.96
(-0.69%)
Dow Jones
7,726.85 -58.79
(-0.76%)
Hang Seng
65,657.92 638.97
(0.98%)
Nikkei 225
10,716.75 8.42
(0.08%)
Forex
USD-INR
95.65 -0.17
(-0.17%)
EUR-INR
109.56 -0.37
(-0.34%)
GBP-INR
127.74 -0.44
(-0.34%)
JPY-INR
0.61 0.00
(-0.29%)

EQUITY - MARKET SCREENER

Bal Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524824
INE083D01012
65.3864135
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BALPHARMA
22.62
171.8
EPS(TTM)
Face Value()
Div & Yield %
4.77
10
1.11
 

gvk power & infrastructure ltd
BPL reports consolidated net loss of Rs 11.27 crore in the March 2026 quarter
May 29,2026
Net Loss of BPL reported to Rs 11.27 crore in the quarter ended March 2026 as against net loss of Rs 17.66 crore during the previous quarter ended March 2025. Sales rose 4.70% to Rs 19.62 crore in the quarter ended March 2026 as against Rs 18.74 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 8.55 crore in the year ended March 2026 as against net profit of Rs 0.09 crore during the previous year ended March 2025. Sales declined 0.31% to Rs 78.12 crore in the year ended March 2026 as against Rs 78.36 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales19.6218.74 5 78.1278.36 0
OPM %-46.029.28 --6.1715.51 -
PBDT-9.0349.16 PL -4.4968.60 PL
PBT-9.6348.56 PL -6.9166.31 PL
NP-11.27-17.66 36 -8.550.09 PL